ARCH Venture Fund X, L.P.

Insider Reports History

Location
Chicago, IL
Signature
/s/ ARCH Venture Fund X, L.P., By: ARCH Venture Partners X, L.P., its General Partner, By: ARCH Venture Partners X, LLC, its General Partner, By: Mark McDonnell,: attorney in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ARCH Venture Fund X, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sana Biotechnology, Inc. 10%+ Owner Common Stock 12,446,022 $68,453,121 $5.50 08 Feb 2024 Indirect

Insider Reports Filed by ARCH Venture Fund X, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SANA Sana Biotechnology, Inc. 08 Feb 2024 3 +$9,999,996 4 10%+ Owner 12 Feb 2024, 17:43
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 10%+ Owner 16 Jun 2021, 19:35